Furthermore, flow cytometry and immunohistochemical staining showed that the infiltration of human CD3+ (Figures 2B, C), CD4+ (Figure 2D) and CD8+ (Figure 2E) T cells in GVHD-targeted organs (lung and liver) were significantly reduced in mice treated with Dara compared with control mice. The gene discussed is CD4; the disease is graft versus host disease.